U.S. markets open in 5 hours 36 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.66-0.39 (-3.53%)
At close: 04:00PM EST
10.66 0.00 (0.00%)
After hours: 04:20PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close11.05
Bid0.00 x 1300
Ask0.00 x 800
Day's Range10.27 - 11.00
52 Week Range6.40 - 15.60
Avg. Volume579,803
Market Cap654.264M
Beta (5Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-3.59
Earnings DateOct 30, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for DYN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Dyne Therapeutics, Inc.
    Analyst Report: AES Corp.AES Corp., based in Arlington, Virginia, is an independent global power company. In addition, the company owns three regulated utilities in the U.S. It generates approximately 32,000 megawatts of electricity. AES has operations in 15 countries, including the United States, Chile, Colombia, Argentina, Brazil, Mexico, India, and Bulgaria. The company has approximately 9,000 employees. The shares are a component of the S&P 500.
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • InvestorPlace

    3 of the Best Cheap Stocks Under $20 to Buy Now: November Edition

    After dropping to 52-week lows, the markets have been rallying lately. That has traders and investors scrambling for cheap stocks under $20 to buy. This bullish sentiment comes amidst a backdrop of sticky inflation and interest rates that are likely to remain elevated for some time. And another factor is the geopolitical events which include real concerns about an escalation of war in the Middle East. For all those reasons, it may not be time to call an all-clear on the market. Nevertheless, wit

  • GlobeNewswire

    Dyne Therapeutics to Present at November Investor Conferences

    WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present at the following investor conferences in November: Stifel 2023 Healthcare Conference, fireside chat on Tuesday, November 14, 2023 at 4:45 p.m. ET in New York Piper Sandler 35th Annual Healthcare Confe


    Dyne Therapeutics Inc (DYN) Reports Q3 2023 Financial Results and Progress in Clinical Trials

    Company's cash position remains strong, R&D expenses increase, and net loss widens